Herpes simplex virus keratitis is an infection of epithelial cells that are present on the surface of the eye. It also causes the retrograde infection of nerves that serve the cornea.
This report contains market size and forecasts of Herpes Simplex Keratitis Treatment in global, including the following market information:
Global Herpes Simplex Keratitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Herpes Simplex Keratitis Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Herpes Simplex Keratitis Treatment companies in 2021 (%)
The global Herpes Simplex Keratitis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Famciclovir Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Herpes Simplex Keratitis Treatment include GlaxoSmithKline, Vectans Pharma, Blistex, Bausch Health, Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla, Jubilant Cadista and Mylan. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Herpes Simplex Keratitis Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Herpes Simplex Keratitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Herpes Simplex Keratitis Treatment Market Segment Percentages, by Type, 2021 (%)
Famciclovir
Valacyclovir
Acyclovir
Others
Global Herpes Simplex Keratitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Herpes Simplex Keratitis Treatment Market Segment Percentages, by Application, 2021 (%)
Topical
Injection
Oral
Global Herpes Simplex Keratitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Herpes Simplex Keratitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Herpes Simplex Keratitis Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Herpes Simplex Keratitis Treatment revenues share in global market, 2021 (%)
Key companies Herpes Simplex Keratitis Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Herpes Simplex Keratitis Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Vectans Pharma
Blistex
Bausch Health
Aurobindo Pharma
Dr. Reddy's Laboratories
Cipla
Jubilant Cadista
Mylan